KOREA LIFE SCIENCE WEEK
HOME EXHIBITION > NextRegenX

NextRegenX

Next-Gen Advanced Regenerative Medicine, Driving Innovation and Collaboration

NextRegenX 2025

International Next-Generation Advanced Regenerative Medicine Industry Exhibition

NextRegenX 2025 is Korea’s first exhibition dedicated to the advanced regenerative medicine industry, following the global trend of specialized regenerative medicine exhibitions established in Japan, the United States, and Europe. Covering core regenerative medicine technologies — including cell and gene therapy, tissue engineering, and biomaterials — as well as next-generation convergence technologies such as AI-based precision medicine, NextRegenX serves as an innovation platform that connects cutting-edge industry technologies with real-world clinical applications, offering valuable opportunities for business partnerships and future growth through networking with industry leaders.

Why NextRegenX 2025?

Connect with Global Industry Leaders

Share the latest technologies and market trends, and establish secure collaborations with global biopharmaceutical companies, research institutes, investors, and regulatory authorities.

Explore Cutting-Edge Regenerative Medicine Technologies

An overview of cutting-edge regenerative medicine technologies and industry innovations, including cell and gene therapy, tissue engineering, 3D bioprinting, biomaterials, and AI-based precision medicine.

Expand Your Business with B2B Networking & Partnerships

Build partnerships and explore new business opportunities through 1:1 business matching with prominent industry representatives, including CMOs, CDMOs, CROs, and Investors.

Gain Insights from Leading Global Forums & Conferences

Explore the latest global trends in clinical and regulatory strategies, investment, and industrial innovation at the International Forum on Advanced Regenerative Medicine Development Strategies and the Open Innovation Investment Conference.

Unlock Global Collaboration & New Business Opportunities

Build international partnerships and drive new business opportunities in a global hub for regenerative medicine that fosters collaboration across R&D, industry, and investment.

EXHIBITS

Cell and Gene Therapies
  • · Immune Cell Therapies (T Cells, NK Cells, etc.)
  • · Next-Generation Cell and Gene Therapies (CAR-T, iPSC-derived Therapies)
  • · Gene Editing Technologies (CRISPR, TALEN, etc.)
  • · Gene Delivery Systems (AAV, Lentiviral Vectors, etc.)
  • · Stem Cell Therapies (Adult Stem Cells, Embryonic Stem Cells)
Innovative Tissue Regeneration and
Biomaterials
  • · 3D Bioprinting and Tissue Engineering
  • · Biocompatible Scaffolds
  • · Biomaterials
  • · Customized Tissue Fabrication and Transplantation Technologies
Precision Regenerative Medicine and
Personalized Therapies
  • · Personalized Therapeutics Platforms
  • · Immune Cell-Based Precision Therapies
  • · Microbiome-Based Regenerative Medicine
  • · Digital Health-Based Therapeutic Solutions
Advanced Biomanufacturing and
Processing Technologies
  • · GMP-Compliant Production Systems for CGT (Cell and Gene Therapies)
  • · Automated Cell Culture and Monitoring Systems
  • · Bioreactors and Single-Use Bioprocessing Technologies
  • · Cell Culture and Expansion Solutions
  • · Quality Assurance and Quality Control (QA/QC)
Digital Regenerative Medicine and
AI-Driven Solutions
  • · AI-Driven Drug Discovery and Development
  • · Digital Biobank
  • · Data-Driven Therapeutic Models
  • · Bio Big Data
  • · Digital Biomarkers
  • · Therapeutic Optimization Solutions
Anti-Aging & Aesthetic
Regenerative Technologies
  • · Global and Domestic Regulatory and Policy Trends
  • · Exosome-Based Regenerative and Anti-Aging Biopharmaceutical Technologies
  • · Microbiome-Based Skin Rejuvenation Solutions
  • · Precision Diagnostic Platforms Based on Aging Biomarkers
  • · Antioxidant Biomaterials and Tissue Regeneration Applications
Regulatory & Market Access
Strategies
  • · Global and Domestic Regulatory and Policy Trends
  • · Quality and Safety Standards
  • · Clinical Research and Treatment Design in Advanced RM
  • · Clinical Trial Design for Biologics Commercialization
  • · Building Global Collaboration Frameworks
Hospital-Industry Clinical
Collaboration Platforms
  • · Hospital-Industry Joint Clinical Research & Collaboration Models
      Clinical Partnering Models for Commercialization of Regenerative Medicine

EVENTS (upcoming)

CONFERENCE /
FORUM
  • · Advanced Regenerative Medicine
      Development Strategy Forum
  • · Pharmaceutical·Bio Business
      Development Strategy Forum
  • · Pharmaceutical·Bio-Health
      Statistic Forum
  • · Development Strategies for
      Microneedles Seminar
  • · Data Integrity Forum
  • · Korea Analytical and Scientific
      Instrument Conferences &
      Show (KASICS)
  • · Automative Laboratory Workshop
IR / TECHNOLOGY
TRANSACTION
  • · Advanced Regenerative Medicine
      Open Innovation & Investment
      Conference
  • · Promising Bio Venture·Startup
      Investment Forum
  • · IPIR (Pharma & Biotech IR)
  • · Technology Transfer &
      Investment Seminar
  • · Exhibitor Presentation
NETWORKING
  • · Exhibitor – Buyer 1:1 Meeting
  • · Company–Medical Institution
      Business Matching Session
  • · Biz-Partnering
  • · Global Networking Reception
      (KOLS BEER PARTY)
KOLS KOREA LAB Book Your Booth